Immuneering Corp
NASDAQ:IMRX

Watchlist Manager

Immuneering Corp

NASDAQ:IMRX

Watchlist

Dividends

Price: 1.71 USD -6.56% Market Closed

Market Cap: 50.7m USD

Have any thoughts about
Immuneering Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 1.71 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IMRX Alert

Immuneering Corp

1.71

-0.12 (-6.56%)

52 Week Range	1.03 8.44
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Immuneering Corp

What unique competitive advantages
does Immuneering Corp hold over its rivals?

What risks and challenges
does Immuneering Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Immuneering Corp.

What unique competitive advantages
does Immuneering Corp hold over its rivals?

What risks and challenges
does Immuneering Corp face in the near future?

Summarize the latest earnings call
of Immuneering Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Immuneering Corp.

Provide P/S
for Immuneering Corp.

Provide P/E
for Immuneering Corp.

Provide P/OCF
for Immuneering Corp.

Provide P/FCFE
for Immuneering Corp.

Provide P/B
for Immuneering Corp.

Provide EV/S
for Immuneering Corp.

Provide EV/GP
for Immuneering Corp.

Provide EV/EBITDA
for Immuneering Corp.

Provide EV/EBIT
for Immuneering Corp.

Provide EV/OCF
for Immuneering Corp.

Provide EV/FCFF
for Immuneering Corp.

Provide EV/IC
for Immuneering Corp.

Show me price targets
for Immuneering Corp made by professional analysts.

What are the Revenue projections
for Immuneering Corp?

How accurate were the past Revenue estimates
for Immuneering Corp?

What are the Net Income projections
for Immuneering Corp?

How accurate were the past Net Income estimates
for Immuneering Corp?

What are the EPS projections
for Immuneering Corp?

How accurate were the past EPS estimates
for Immuneering Corp?

What are the EBIT projections
for Immuneering Corp?

How accurate were the past EBIT estimates
for Immuneering Corp?

Compare the revenue forecasts
for Immuneering Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Immuneering Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Immuneering Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Immuneering Corp compared to its peers.

Compare the P/E ratios
of Immuneering Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Immuneering Corp with its peers.

Analyze the financial leverage
of Immuneering Corp compared to its main competitors.

Show all profitability ratios
for Immuneering Corp.

Provide ROE
for Immuneering Corp.

Provide ROA
for Immuneering Corp.

Provide ROIC
for Immuneering Corp.

Provide ROCE
for Immuneering Corp.

Provide Gross Margin
for Immuneering Corp.

Provide Operating Margin
for Immuneering Corp.

Provide Net Margin
for Immuneering Corp.

Provide FCF Margin
for Immuneering Corp.

Show all solvency ratios
for Immuneering Corp.

Provide D/E Ratio
for Immuneering Corp.

Provide D/A Ratio
for Immuneering Corp.

Provide Interest Coverage Ratio
for Immuneering Corp.

Provide Altman Z-Score Ratio
for Immuneering Corp.

Provide Quick Ratio
for Immuneering Corp.

Provide Current Ratio
for Immuneering Corp.

Provide Cash Ratio
for Immuneering Corp.

What is the historical Revenue growth
over the last 5 years for Immuneering Corp?

What is the historical Net Income growth
over the last 5 years for Immuneering Corp?

What is the current Free Cash Flow
of Immuneering Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Immuneering Corp.

IMRX

Income Statement

Income from Continuing Operations

Immuneering Corp
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Immuneering Corp
Income from Continuing Operations Peer Comparison

Comparables:

ABBV

GILD

AMGN

VRTX

REGN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company		Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
I	Immuneering Corp NASDAQ:IMRX	Income from Continuing Operations -$53.5m	CAGR 3-Years -46%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Income from Continuing Operations $5.1B	CAGR 3-Years -12%	CAGR 5-Years 9%	CAGR 10-Years 3%
	Gilead Sciences Inc NASDAQ:GILD	Income from Continuing Operations $113m	CAGR 3-Years -75%	CAGR 5-Years -47%	CAGR 10-Years -36%
	Amgen Inc NASDAQ:AMGN	Income from Continuing Operations $4.2B	CAGR 3-Years -9%	CAGR 5-Years -12%	CAGR 10-Years -1%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Income from Continuing Operations -$479.8m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 2%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Income from Continuing Operations $4.7B	CAGR 3-Years -13%	CAGR 5-Years 17%	CAGR 10-Years 30%

What is Immuneering Corp's Income from Continuing Operations?

Income from Continuing Operations
-53.5m USD

Based on the financial report for Dec 31, 2023, Immuneering Corp's Income from Continuing Operations amounts to -53.5m USD.

What is Immuneering Corp's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 3Y
-46%

Over the last year, the Income from Continuing Operations growth was -6%. The average annual Income from Continuing Operations growth rates for Immuneering Corp have been -46% over the past three years .

Immuneering Corp
NASDAQ:IMRX

Immuneering Corp
Income from Continuing Operations

Immuneering Corp
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Immuneering Corp's Income from Continuing Operations?

Income from Continuing Operations
-53.5m USD

What is Immuneering Corp's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 3Y
-46%

Company

Help

Tools

Stocks

Immuneering Corp NASDAQ:IMRX

Immuneering Corp Income from Continuing Operations

Immuneering Corp Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Immuneering Corp's Income from Continuing Operations? Income from Continuing Operations -53.5m USD

What is Immuneering Corp's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 3Y -46%

Company

Help

Tools

Stocks

Immuneering Corp
NASDAQ:IMRX

Immuneering Corp
Income from Continuing Operations

Immuneering Corp
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Immuneering Corp's Income from Continuing Operations?

Income from Continuing Operations
-53.5m USD

What is Immuneering Corp's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 3Y
-46%